
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology |
Department of Virus-Host Interactions [Q. S., R. B., C. H. S.] and Biostatistics Unit [L. E.], Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany; Departments of Pathology [Q. S., S-F. W.] and Clinical Diagnostics [T-E. C.], Tangdu Hospital, The Fourth Military Medical University, Xian, 710038 China; University of Lübeck, 23538 Lübeck, Germany [H. H.]; and Takegoshi Internal Medicine Clinic, Takaoka, 9330014 Japan [K. T.]
Purpose: Beside the established maturation of hepatitis B virus (HBV) transcripts at a polyadenylation signal downstream of the HBV x protein open reading frame, maturation at an internal polyadenylation signal has been observed in the chronically infected liver. In the present study, it was the aim to identify the respective circulating full-length and truncated transcripts in plasma/serum of carriers.
Experimental Design: Nucleic acids extracted from sera were analyzed using established PCR and reverse transcription-PCR procedures targeted to HBV x protein gene regions. Amplification products were cloned and sequenced.
Results: Base substitution patterns were determined, which indicated infection stages advanced to different degrees regardless of the transcript type analyzed. HBV full-length RNA (fRNA) showed a high correlation with hepatitis B e antigen and viral DNA, indicative for a replicative infection. In contrast, truncated RNA (trRNA) appeared to be independent of hepatitis B e antigen and showed only a weak association with circulating viral DNA. No correlation was observed between the levels of trRNA and the apparent liver damage as reflected by alanine transaminase levels. An age-dependent representation of fRNA and trRNA was observed: fRNA decreased progressively to low levels, whereas trRNA remained at comparably high values. trRNA and RNA not polyadenylated at either of the two polyadenylation signals were detected even in the absence of any other conventional HBV seromarker, including viral DNA. This was shown for patients with cryptogenic cirrhosis and hepatitis C virus carriers.
Conclusions: The identification of HBV RNA in human serum has a diagnostic potential for apparent and for inapparent infection stages.
This article has been cited by other articles:
![]() |
H. JORG HACKER, W. ZHANG, M. TOKUS, T. BOCK, and C. H. SCHRODER Patterns of Circulating Hepatitis B Virus Serum Nucleic Acids during Lamivudine Therapy Ann. N.Y. Acad. Sci., June 1, 2004; 1022(1): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hennig, I. Puchta, J. Luhm, P. Schlenke, S. Goerg, and H. Kirchner Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen Blood, September 18, 2002; 100(7): 2637 - 2641. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Johnson and Y.M. D. Lo Plasma Nucleic Acids in the Diagnosis and Management of Malignant Disease Clin. Chem., August 1, 2002; 48(8): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. BREITKREUTZ, W. ZHANG, M. LEE, A. HOFFMANN, M. TOKUS, Q. SU, and C. H. SCHRODER Hepatitis B Virus Nucleic Acids Circulating in the Blood: Distinct Patterns in HBs Carriers with Hepatocellular Carcinoma Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 195 - 206. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |